简介
Eric Dunbar is an associate in the Intellectual Property Transactions Group.
Prior to joining Shearman & Sterling, Eric was an associate at an intellectual property, antitrust and corporate law boutique primarily handling intellectual property counseling matters, including intellectual property litigation, for pharmaceutical, medical device and technology companies.
经验
- Intercontinental Exchange, Inc. in its pending acquisition of Black Knight, Inc., a deal valued at approximately $13 billion.
- Anglo American in its ongoing combination of First Mode with Anglo American’s nuGen Zero Emissions Haulage Solution.
- SAP SE in its pending sale of SAP Litmos to Francisco Partners.
- A prominent media and broadcasting company in connection with partnerships for the creation, distribution and exploitation of digital content.
- A sovereign wealth fund in connection with partnerships for the rebranding and operation of luxury hotel properties.
- A precision medicine company in connection with a data collaboration leveraging molecular profiling data with clinical documentation.
资格
-
教育
波士顿大学法学院
芝加哥大学
B.A., Biological Science, Public Policy
-
律师执业许可
-
有资格出庭的法院
- 美国地区法院纽约南区法院
- 美国地区法院纽约东区法院
个人成就
Publications
- E. Dunbar and C. Landmon, IP and Collaboration, 41 Pharmaceutical Executive, 21-22 (Mar. 11, 2021)
- E. Dunbar and C. Landmon, Insights on the MODERN Labeling Act, Axinn FDA Update (Nov. 20, 2020
- E. Dunbar and J. Harris, Prosecution Counsel Beware: Statutory Bars and Inequitable Conduct, Axinn IP Update
Mar. 19, 2020)
- E. Dunbar, et al., 3 Strategies to Manage Case Scope in ANDA Patent Litigation, Law360 (Dec. 10, 2019)
- E. Dunbar and C. Landmon, Status Quo Maintained: FDA Reverses Course on Generic Product Labeling, FDLI Update, 29-32 (Mar. 1, 2019)